Clinical impact of peripheral attacks in hereditary angioedema patients.

[1]  E. S. Amersfoort,et al.  Recombinant C1-Inhibitor , 2012, BioDrugs.

[2]  M. Cicardi,et al.  Target levels of functional C1‐inhibitor in hereditary angioedema , 2012, Allergy.

[3]  J. Nuijens,et al.  Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. , 2010, The Journal of allergy and clinical immunology.

[4]  William H. Yang,et al.  Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. , 2010, The New England journal of medicine.

[5]  Francesco Tedesco,et al.  Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. , 2009, The Journal of allergy and clinical immunology.

[6]  T. Craig,et al.  Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks. , 2009, Allergy and asthma proceedings.

[7]  B. Zuraw.  Clinical practice. Hereditary angioedema. , 2008, The New England journal of medicine.

[8]  A. Tordai,et al.  Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: functional and structural correlates. , 2008, Molecular immunology.

[9]  K. Bork,et al.  Treatment of skin swellings with C1‐inhibitor concentrate in patients with hereditary angio‐oedema , 2008, Allergy.

[10]  M. Frank.  8. Hereditary angioedema. , 2008, The Journal of allergy and clinical immunology.

[11]  H. Farkas,et al.  Recombinant human C1‐inhibitor in the treatment of acute angioedema attacks , 2007, Transfusion.

[12]  K. Bork,et al.  Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.

[13]  K. Bork,et al.  Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema , 2005, Transfusion.

[14]  A. Eerenberg,et al.  A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema. , 2005, The Journal of allergy and clinical immunology.

[15]  B. Hoggart,et al.  Pain: a review of three commonly used pain rating scales. , 2005, Journal of clinical nursing.

[16]  M. Gompels,et al.  C1 inhibitor deficiency: consensus document , 2005, Clinical and experimental immunology.

[17]  A. Tordai,et al.  Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.

[18]  M. Cicardi,et al.  Bradykinin-mediated angioedema. , 2002, The New England journal of medicine.

[19]  P. Bijur,et al.  Reliability and validity of a visual analog scale for acute abdominal pain in the ED. , 2002, The American journal of emergency medicine.

[20]  A. Davis,et al.  Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. , 2002, The Journal of clinical investigation.

[21]  W. Tremaine,et al.  Hereditary angioedema: a broad review for clinicians. , 2001, Archives of internal medicine.

[22]  K. Bork,et al.  Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. , 2001, Archives of internal medicine.

[23]  K. Bork,et al.  Asphyxiation by laryngeal edema in patients with hereditary angioedema. , 2000, Mayo Clinic proceedings.

[24]  H. McQuay,et al.  The visual analogue pain intensity scale: what is moderate pain in millimetres? , 1997, PAIN.

[25]  K. Todd,et al.  Clinical significance of reported changes in pain severity. , 1996, Annals of emergency medicine.

[26]  M. Cicardi,et al.  Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.

[27]  B. Lämmle,et al.  Detection and Quantitation of Cleaved and Uncleaved High Molecular Weight Kininogen in Plasma by Ligand Blotting with Radiolabeled Plasma Prekallikrein or Factor XI , 1988, Thrombosis and Haemostasis.

[28]  B. Lämmle,et al.  Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies. , 1986, Blood.

[29]  F. Rosen,et al.  Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema. , 1971, The Journal of clinical investigation.